glp 1 and loss of muscle mass Study finds GLP-1 receptor agonists target fat over for weight GLP-1 Muscle Protection Guide |

doi: 10.3390/cells14171335 39 WangZWanYMengXZhangXYaoMMiuWet al

In a RCT comparing low- to intermediate-risk PCa patients treated with either surgery or RT (without ADT), the sexual function scores of the Expanded Prostate Index Composite (EPIC-26) were significantly higher for men receiving RT at two years post-treatment [306]

Local Manufacturing And Fill-Finish Investments Lower Supply Risk Novo Nordisks USD 1.09 billion upgrade to its Montes Claros complex, announced in April 2025, will begin producing GLP-1 pens domestically in late 2026, shielding the Latin America GLP-1 agonists market from future import bottlenecks

Falutz, J., Potvin, D., Mamputu, J., Assaad, H., Zoltowska, M., Michaud, S., & Grinspoon, S